Literature DB >> 9594953

Drug-related hospital admissions: a review of Australian studies published 1988-1996.

E E Roughead1, A L Gilbert, J G Primrose, L N Sansom.   

Abstract

OBJECTIVE: To examine the extent of drug-related hospital admissions in Australia by reviewing Australian studies published between 1988 and 1996. DATA SOURCES AND STUDY SELECTION: The terms "drug-related", "admissions", "readmissions", "hospitalisation", "hospitalization" and "iatrogenic" were used to search MEDLINE and Australian Public Affairs Information Service databases. The Australian Journal of Hospital Pharmacy and conference proceedings of the Society of Hospital Pharmacists and the Australasian Pharmaceutical Science Association were searched manually. Studies were included if they were Australian, had the primary aim of identifying drug-related admissions, and had at least one clinical pharmacist or medical practitioner review the admissions. DATA EXTRACTION: Total number of admissions assessed; proportion considered drug-related; drug groups implicated; and proportion considered avoidable. DATA SYNTHESIS: 14 studies were identified; 2.4%-3.6% of all hospital admissions were reported to be drug-related. 6%-7% of emergency admissions, 12% of all admissions to medical wards and 15%-22% of all emergency admissions among the elderly were drug related. Between 32% and 69% of drug-related admissions were reported as definitely or possibly preventable. Drug groups most commonly implicated were cytotoxics, cardiovascular agents, antihypertensives, anticoagulants and non-steroidal anti-inflammatory drugs.
CONCLUSION: Drug-related hospital admissions are a significant and expensive public health problem in Australia, and approximately half were considered possibly or probably preventable.

Entities:  

Mesh:

Year:  1998        PMID: 9594953

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  50 in total

1.  Admissions to hospital caused by adverse drug reactions: cross sectional incidence study. French Pharmacovigilance Centres.

Authors:  P Pouyanne; F Haramburu; J L Imbs; B Bégaud
Journal:  BMJ       Date:  2000-04-15

Review 2.  Methods and systems to detect adverse drug reactions in hospitals.

Authors:  P A Thürmann
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

3.  First results from an intensified monitoring system to estimate drug related hospital admissions.

Authors:  S Schneeweiss; M Göttler; J Hasford; W Swoboda; M Hippius; A K Hoffmann; A K Riethling; J Krappweis
Journal:  Br J Clin Pharmacol       Date:  2001-08       Impact factor: 4.335

4.  Multidisciplinary medication review in nursing home residents: what are the most significant drug-related problems? The Bergen District Nursing Home (BEDNURS) study.

Authors:  S Ruths; J Straand; H A Nygaard
Journal:  Qual Saf Health Care       Date:  2003-06

Review 5.  Pharmaceutical care programmes for the elderly: economic issues.

Authors:  Grainne E Crealey; Ian K Sturgess; James C McElnay; Carmel M Hughes
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

Review 6.  Factors influencing the implementation of quality use of medicines in residential aged care.

Authors:  Julianne Cheek; Andrew Gilbert; Alison Ballantyne; Robert Penhall
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

7.  Frequency and characteristics of hospital admissions associated with drug-related problems in paediatrics.

Authors:  Kylie L Easton; Colin B Chapman; Jo-anne E Brien
Journal:  Br J Clin Pharmacol       Date:  2004-05       Impact factor: 4.335

8.  Prevalence and factors associated with polypharmacy in older people with cancer.

Authors:  Justin P Turner; Sepehr Shakib; Nimit Singhal; Jonathon Hogan-Doran; Robert Prowse; Sally Johns; J Simon Bell
Journal:  Support Care Cancer       Date:  2014-03-02       Impact factor: 3.603

9.  Detection of adverse drug reactions in a neurological department: comparison between intensified surveillance and a computer-assisted approach.

Authors:  Petra A Thuermann; Roland Windecker; Joachim Steffen; Markus Schaefer; Ute Tenter; Erich Reese; Hermann Menger; Klaus Schmitt
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

10.  Congruence on medication between patients and physicians involved in patient course.

Authors:  S Foss; J R Schmidt; T Andersen; J J Rasmussen; J Damsgaard; K Schaefer; L K Munck
Journal:  Eur J Clin Pharmacol       Date:  2003-12-19       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.